Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
This study is ongoing, but not recruiting participants.
Sponsor:
Trophos
Collaborator:
Association Française contre les Myopathies (AFM), Paris
Information provided by (Responsible Party):
Trophos
ClinicalTrials.gov Identifier:
NCT01302600
First received: February 18, 2011
Last updated: December 27, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |